Close Menu

GOTHENBURG, Sweden (GenomeWeb) – Noninvasive prenatal genetic tests for detecting fetal disorders and preconception tests to assess disease recurrence risk continue to advance. At the European Human Genetics Conference here in Gothenburg yesterday, researchers presented two new noninvasive prenatal testing methods and a new way to determine recurrence risk for diseases caused by a de novo mutation.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.